Internal Medicine, Rheumatology · Jackson Heights, NY
NPI
1629165162
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3713 85th St Bsmt
Jackson Heights, NY, 11372
Phone (718) 507-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
290 services
Medicare patients, 2024
86
Average age 72
Drug cost, 2024
$5.7M
13,456 prescriptions
Company payments, 2025
$59K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eneida Agosto-Colon was code 99213 (office e&m - established), 141 times for 65 patients. In total Eneida Agosto-Colon billed 290 services in 11 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 141 | 65 | $73.92 | $10K |
| 99214 Office E&M - Established | Office | 53 | 27 | $107.95 | $5,721 |
| 96372 Injection Administration | Office | 29 | 14 | $12.42 | $360 |
| 99204 Office E&M - New | Office | 23 | 23 | $141.38 | $3,252 |
| 20550 Musculoskeletal | Office | 13 | 11 | $49.19 | $639 |
By year: 2022 $23K for 313 services; 2023 $26K for 372 services; 2024 $21K for 290 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eneida Agosto-Colon prescribed most often to Medicare patients was Gabapentin, with 1,669 prescriptions and refills. In total Eneida Agosto-Colon wrote 13,456 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,669 | 1,802 | 346 | $11K |
| Tizanidine Hcl Generic | 1,487 | 1,563 | 348 | $6,116 |
| Diclofenac Sodium Generic | 1,069 | 1,380 | 262 | $434K |
| Celecoxib Generic | 729 | 777 | 188 | $21K |
| Fluocinonide Generic | 526 | 526 | 125 | $81K |
| Lidocaine Generic | 472 | 854 | 170 | $84K |
| Methotrexate Methotrexate Sodium | 434 | 548 | 70 | $7,172 |
| Alendronate Sodium Generic | 424 | 482 | 80 | $2,137 |
| Sulindac Generic | 415 | 421 | 112 | $5,298 |
| Duloxetine Hcl Generic | 324 | 342 | 52 | $4,919 |
| Escitalopram Oxalate Generic | 308 | 346 | 64 | $1,738 |
| Hydroxychloroquine Sulfate Generic | 295 | 361 | 52 | $5,623 |
| Cyclobenzaprine Hcl Generic | 283 | 313 | 54 | $1,726 |
| Pregabalin Generic | 281 | 281 | 51 | $6,115 |
| Prednisone Generic | 278 | 292 | 69 | $1,044 |
Brand drugs: 1,812 claims; generic drugs: 11,632 claims; opioid claims: 140.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eneida Agosto-Colon $59K ($59K in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 62 | $30K |
| Janssen Biotech, Inc. JNJ | 53 | $14K |
| AstraZeneca Pharmaceuticals LP AZN | 24 | $9,272 |
| GlaxoSmithKline, LLC. GSK | 10 | $3,476 |
| UCB, Inc. UCB.BR | 12 | $552 |
| Amgen Inc. AMGN | 14 | $358 |
| ANI Pharmaceuticals, Inc. ANIP | 9 | $201 |
| Revance Therapeutics, Inc. | 1 | $148 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $147 |
| Scilex Pharmaceuticals Inc. | 22 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.